Sigma Partners is the famous VC, which was founded in 1984. The company was established in North America in United States. The main office of represented VC is situated in the Boston.
The average startup value when the investment from Sigma Partners is 50-100 millions dollars. Comparing to the other companies, this Sigma Partners performs on 9 percentage points less the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2010. The high activity for fund was in 2008. Despite it in 2019 the fund had an activity. The fund is constantly included in 13-24 deals per year. Speaking about the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Enterprise Software, Internet. Among the various public portfolio startups of the fund, we may underline ChinaCache, DocuSign, Octane Software
The overall number of key employees were 3.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Sigma Partners, startups are often financed by Kepha Partners, Ignition Partners, Highland Capital Partners. The meaningful sponsors for the fund in investment in the same round are Kodiak Venture Partners, Ignition Partners, HLM Venture Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Jackson Square Ventures, JAFCO Asia.
|26M||10 Sep 2019||United States, Concord|
|17 Aug 2017|
|65M||25 May 2017||United States, San Francisco|
|18M||05 Jan 2017||United States, Boston|
|17M||13 Dec 2016||United States, Boston|
|33M||05 Oct 2016||United States, Denver|
|56M||09 Aug 2016||United States, " United States"}|
|88M||19 May 2016||United States, " United States"}|
BionX™ Medical Technologies
|17M||23 Dec 2015||United States, " United States"}|
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.